Collaborative Clinical Research for Better Patient Outcomes will be the theme of the 11th Annual Conference of the Indian Society for Clinical Research (ISCR) which will be held at JW Marriott, Bangalore, from January 19th to 20th. The two-day event is focused on bringing together different stakeholders across the clinical research continuum on a common platform to deliberate on the future that the clinical research fraternity in India needs to take in an improved regulatory environment.
Stakeholders will meet and deliberate on opportunities to learn, partner and collaborate while strengthening the ethical conduct of clinical research and creating better outcomes for patients. India has the second largest population in the world and 1/5th of the global disease burden and yet, less than 1.4% of global clinical research is conducted in the country. Around 400-500 clinical research professionals are expected to attend the event.
Leading up to the annual conference, five pre-conference workshops have been scheduled for the clinical researcher fraternity and medical and pharma students on January 17th and 18th. These workshops will focus on principles of evidence based medicine and its applicability in India, career opportunities in clinical research and associated fields, pharmacovigilance (PV) audits and inspections, role of clinical pharmacology in drug discovery and development and risk based monitoring in clinical trials.
For more information, please visit http://www.iscr.org/iscr-conference-2018/
The Indian Society for Clinical Research (ISCR) is an association of clinical research professionals that aims to build awareness of clinical research as a specialty in India and to facilitate its growth in the country while helping to evolve the highest standards of quality and ethics. To that extent, we are fully supportive of the initiatives undertaken by regulatory authorities to create a more robust and regulated environment in India for the conduct of clinical research and will continue to work very closely with different stakeholders in the development of regulations that will safeguard and protect patients in a clinical trial. For more information, visit www.iscr.org